The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
The Current State of Peptide Drug Discovery: Back to the Future?
Abstract
Over the past decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role that peptide therapeutics can play in addressing unmet medical needs and how this class of compounds can be an excellent complement or even preferable alternative to small molecule and biological therapeutics. In this Perspective, we give a concise description of the recent progress in peptide drug discovery in a holistic manner, highlighting enabling technological advances affecting nearly every aspect of this field: from lead discovery, to synthesis and optimization, to peptide drug delivery. An emphasis is placed on describing research efforts to overcome the inherent weaknesses of peptide drugs, in particular their poor pharmacokinetic properties, and how these efforts have been critical to the discovery, design, and subsequent development of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–261 of 261
Overcoming bottlenecks in the membrane protein structural biology pipeline
Hardy, D., Bill, R. M., Jawhari, A., & Rothnie, A. J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160049 · Cited by 66
The expanding world of DNA and RNA
Chen, T., Hongdilokkul, N., Liu, Z., Thirunavukarasu, D., & Romesberg, F. E. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.08.001 · Cited by 65
Zhao, L., & Lu, W. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.019 · Cited by 64
Xie, J., Zhang, H., Yea, K., & Lerner, R. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306263110 · Cited by 63
Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog
Léger, R., Thibaudeau, K., Robitaille, M., Quraishi, O., van Wyk, P., Bousquet-Gagnon, N., Carette, J., Castaigne, J., & Bridon, D. P. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.066 · Cited by 63
Rembratt, A., Graugaard-Jensen, C., Senderovitz, T., Norgaard, J., & Djurhuus, J. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0781-9 · Cited by 62
Calcott, M. J., & Ackerley, D. F. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1642-y · Cited by 61
Humanin and the Receptors for Humanin
Matsuoka, M., & Hashimoto, Y. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8090-z · Cited by 60
Selection-based discovery of macrocyclic peptides for the next generation therapeutics
Morioka, T., Loik, N. D., Hipolito, C. J., Goto, Y., & Suga, H. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.01.023 · Cited by 60
Schaepelynck, P., Darmon, P., Molines, L., Jannot-Lamotte, M.-F., Tréglia, C., & Raccah, D. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70972-7 · Cited by 60
The depsipeptide method for solid‐phase synthesis of difficult peptides
Coin, I. (2010) · Journal of Peptide Science · doi:10.1002/psc.1224 · Cited by 55
O’Connor‐Semmes, R., Lin, J., Hodge, R. J., Andrews, S. M., Chism, J. P., Choudhury, A., & Nunez, D. J. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.187 · Cited by 55
Phage Display Selections for Affinity Reagents to Membrane Proteins in Nanodiscs
Dominik, P. K., & Kossiakoff, A. A. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.12.032 · Cited by 54
Castelli, M., Wong, D. F., Friedman, K., & Riley, M. G. I. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.05.088 · Cited by 54
Protein chemical synthesis by α-ketoacid–hydroxylamine ligation
Harmand, T. J., Murar, C. E., & Bode, J. W. (2016) · Nature Protocols · doi:10.1038/nprot.2016.052 · Cited by 53
Advancements in therapeutically targeting orphan GPCRs
Stockert, J. A., & Devi, L. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00100 · Cited by 51
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
Hannig, G., Tchernychev, B., Kurtz, C. B., Bryant, A. P., Currie, M. G., & Silos‐Santiago, I. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00031 · Cited by 51
Perry, L., Jones, T. D., & Baker, M. (2008) · Drugs in R&D · doi:10.2165/0126839-200809060-00004 · Cited by 51
Subirós‐Funosas, R., El‐Faham, A., & Alberício, F. (2011) · Biopolymers · doi:10.1002/bip.21713 · Cited by 51
Murray, J. K., Qian, Y., Liu, B., Elliott, R., Aral, J., Park, C., Zhang, X., Stenkilsson, M., Salyers, K. L., Rose, M. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00495 · Cited by 51
Bajo, A. M., Schally, A. V., Halmos, G., & Nagy, A. (2003) · PubMed · Cited by 50
Hoang, H. N., Song, K., Hill, T. A., Derksen, D. R., Edmonds, D. J., Kok, W. M., Limberakis, C., Liras, S. I., Loria, P. M., Mascitti, V., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00166 · Cited by 49
Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs
Chan, Y.-P., Meyrueix, R., Kravtzoff, R., Nicolas, F., & Lundstrom, K. H. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.441 · Cited by 49
New, Potent, Selective, and Short-Acting Peptidic V1aReceptor Agonists
Wiśniewski, K., Galyean, R., Tariga, H., Alagarsamy, S., Croston, G. E., Heitzmann, J., Kohan, A., Wiśniewska, H., Laporte, R., Rivière, P. J.-M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200278m · Cited by 47
de Serres, M., Ellis, B., Dillberger, J. E., Rudolph, S. K., Hutchins, J. T., Boytos, C. M., Weigl, D., & DePrince, R. B. (1999) · Stem Cells · doi:10.1002/stem.170203 · Cited by 46
The power, pitfalls and potential of the nanodisc system for NMR-based studies
Viegas, A., Viennet, T., & Etzkorn, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0224 · Cited by 46
Fragment Condensation of C‐Terminal Pseudoproline Peptides without Racemization on the Solid Phase
Heinlein, C., Silva, D. V., Tröster, A., Schmidt, J., Gross, A., & Unverzagt, C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101270 · Cited by 43
Henry, R. R., Rosenstock, J., Logan, D. K., Alessi, T. R., Luskey, K. L., & Baron, M. A. (2013) · Diabetes Care · doi:10.2337/dc12-2410 · Cited by 42
Laporte, R., Kohan, A., Heitzmann, J., Wiśniewska, H., Toy, J., La, E., Tariga, H., Alagarsamy, S., Ly, B., Dykert, J., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.178848 · Cited by 41
Editorial: Orphan GPCRs As Emerging Drug Targets
Ye, F., Kenakin, T., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00295 · Cited by 41
Efforts toward broadening the spectrum of arylomycin antibiotic activity
Liu, J., Smith, P. A., Steed, D. B., & Romesberg, F. E. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.026 · Cited by 40
Eustache, S., Leprince, J., & Tufféry, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1201058 · Cited by 40
Cell-penetrating peptides - Methods and protocols
Redi, C. A. (2011) · European Journal of Histochemistry · doi:10.4081/ejh.2011.br10 · Cited by 39
Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist
Cheloha, R. W., Watanabe, T., Dean, T., Gellman, S. H., & Gardella, T. J. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00404 · Cited by 39
Next-Generation Sequencing of Phage-Displayed Peptide Libraries
Matochko, W. L., & Derda, R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2020-4_17 · Cited by 38
Recent Advances Toward the Discovery of Drug-Like Peptides De novo
Goldflam, M., & Ullman, C. G. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00069 · Cited by 37
Miranda, L. P., Holder, J. R., Shi, L., Bennett, B. D., Aral, J., Gegg, C. V., Wright, M., Walker, K. W., Doellgast, G. J., Rogers, R., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8009298 · Cited by 35
The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
Christensen, M., Miossec, P., Larsen, B. D., Werner, U., & Knop, F. K. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.942638 · Cited by 34
A New Approach to Search for the Bioactive Conformation of Glucagon: Positional Cyclization Scanning
Ahn, J.-M., Gitu, P. M., Medeiros, M. K., Swift, J. R., Trivedi, D. B., & Hruby, V. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010091q · Cited by 34
A C-terminal Membrane Anchor Affects the Interactions of Prion Proteins with Lipid Membranes
Chu, N. K., Shabbir, W., Bove‐Fenderson, E., Araman, C., Lemmens‐Gruber, R., Harris, D. A., & Becker, C. F. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587345 · Cited by 32
Agonists of luteinizing hormone-releasing hormone in prostate cancer
Rick, F. G., Block, N. L., & Schally, A. V. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.834328 · Cited by 27
The Expanding Role of Therapeutic Antibodies
Salemi, S., Marković, M., Martini, G., & D’Amelio, R. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2013.863304 · Cited by 27
Harris, P. W. R., Kowalczyk, R., Hay, D. L., & Brimble, M. A. (2012) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-012-9325-9 · Cited by 26
Miller, L. J., Sexton, P. M., Dong, M., & Harikumar, K. G. (2014) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2014.4 · Cited by 24
Patil, N. A., Tailhades, J., Karas, J. A., Separovic, F., Wade, J. D., & Hossain, M. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604733 · Cited by 24
Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural Optimization
Mroz, P. A., Pérez–Tilve, D., Liu, F., Gelfanov, V. M., DiMarchi, R. D., & Mayer, J. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00840 · Cited by 22
Lim, S. I., & Kwon, I. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1048504 · Cited by 21
Vasilescu, A.-N., Schweinfurth, N., Borgwardt, S., Gass, P., Lang, U. E., Inta, D., & Eckart, S. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s119004 · Cited by 21
Sortase‐Based Bio‐organic Strategies for Macromolecular Synthesis
Haridas, V., Sadanandan, S., & Dheepthi, N. U. (2014) · ChemBioChem · doi:10.1002/cbic.201402013 · Cited by 20
Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes
Hu, M. L., Zhang, Y., Xiang, N., Zhong, Y., Gong, T., Zhang, Z., & Fu, Y. S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1873-9 · Cited by 20
Chemical Posttranslational Modification of Phage-Displayed Peptides
Ng, S., Tjhung, K. F., Paschal, B. M., Noren, C. J., & Derda, R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2020-4_11 · Cited by 18
Zhang, H., Du, M., Xie, J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603052 · Cited by 18
Schneider, E. L., Henise, J., Reid, R. R., Ashley, G. W., & Santi, D. V. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00188 · Cited by 17
Medicinal Chemistry of Glucagon-Like Peptide Receptor Agonists
Jones, L. H., & Price, D. A. (2013) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-62652-3.00002-8 · Cited by 17
Frey, V., Viaud, J., Subra, G., Cauquil, N., Guichou, J., Casara, P., Grassy, G., & Chavanieu, A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.06.008 · Cited by 16
Sandiford, S. K. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.877882 · Cited by 16
Zhang, H., Xie, J., & Lerner, R. A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.085 · Cited by 15
Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation
Rothstein, R. D., & Friedenberg, F. K. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.833605 · Cited by 13
Peng, Y., Zeng, W., Ye, H., Han, K. H., Dharmarajan, V., Novick, S. J., Wilson, I. A., Griffin, P. R., Friedman, J. M., & Lerner, R. A. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.011 · Cited by 11
Yoshimoto, N., Tatematsu, K., Iijima, M., et al. (2014) · Scientific Reports · doi:10.1038/srep04242 · Cited by 11
Comparison of the immunogenicity of wasp venom peptides with or without carbohydrate moieties
Ho, C. L., Lin, Y.-L., Chen, W.-C., Rocchi, R., & Piek, T. (1998) · Toxicon · doi:10.1016/s0041-0101(97)00066-4 · Cited by 8
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production
Isidro-Llobet, A., Kenworthy, M. N., Mukherjee, S., Kopach, M. E., Wegner, K., Gallou, F., Smith, A. G., & Roschangar, F. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b03001 · Cited by 473
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Metadata
- Authors
- Henninot, A., Collins, J. C., & Nuss, J. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-08-11
- Volume
- 61
- Issue
- 4
- Pages
- 1382-1414
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2739354616
- Cited by
- 1,113
- References
- 261
- FWCI
- 29.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.